Alaunos Therapeutics (TCRT) Net Cash Flow (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Net Cash Flow of -$1.0 million for Q1 2026, down 33.55% on a YoY basis from -$1.6 million in Q1 2025, and down 86.44% quarter-over-quarter from -$553000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Net Cash Flow (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Net Cash Flow for 18 years, with the latest figure at -$1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 33.55% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$3.1 million (up 18.22% YoY), and the FY2025 full-year result was $294000.0, up 105.91% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$1.0 million, down from -$553000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $1.3 million in Q4 2022, with the low at -$19.1 million in Q2 2023.
- Historically, Net Cash Flow has averaged -$4.6 million across 5 years, with a median of -$1.7 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow soared 107.98% — and 2023, when it plunged 570.18%.
- Alaunos Therapeutics' Net Cash Flow stood at $1.3 million in 2022, then sank by 570.18% to -$5.9 million in 2023, then jumped by 89.94% to -$592000.0 in 2024, then advanced by 6.59% to -$553000.0 in 2025, then plunged by 86.44% to -$1.0 million in 2026.
- The last three Net Cash Flow figures came in at -$1.0 million (Q1 2026), -$553000.0 (Q4 2025), and -$844000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | -1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 Mn |
| Mar 31, 2026 | -1.03 Mn |
| Dec 31, 2025 | -553,000.00 |
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Sep 30, 2025 | -844,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -701,000.00 |
| Mar 31, 2025 | -772,000.00 |
| Mar 31, 2025 | -772,000.00 |
| Dec 31, 2024 | -592,000.00 |
| Dec 31, 2024 | -592,000.00 |
| Sep 30, 2024 | -781,000.00 |
| Sep 30, 2024 | -781,000.00 |
| Jun 30, 2024 | -1.68 Mn |
| Jun 30, 2024 | -1.68 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Mar 31, 2024 | -1.92 Mn |
| Dec 31, 2023 | -5.88 Mn |
| Dec 31, 2023 | -5.88 Mn |